OSCR

Gut microbiota and its association with gastrointestinal symptoms and pharmacological treatments in a sibling-matched cohort with autism spectrum disorder.

Overview

Authors: Florencia Peñalba1, Andreina Guisande2, Lucía Lamberti3, Camila Rusiñol3, Maite Irastorza1, Florencia Konik4, Claudio Iglesias2, Paula Mendive4, Gabriela Garrido3, Andrés Parada1, Nadia Riera1,5
ORCID iDs: Nadia Riera
  1. Microbial Genomics Laboratory, Institut Pasteur de Montevideo, Montevideo, Uruguay
  2. Department of Pediatric Gastroenterology, Hepatology and Nutrition, Pereira Rossell Hospital Center, Montevideo, Uruguay
  3. Academic Unit of Pediatric Psychiatry, School of Medicine, University of the Republic, Montevideo, Uruguay
  4. Unidad Académica (U.A.) Área de Investigación, Escuela de Nutrición, Universidad de la República, Montevideo, Uruguay
  5. Center for Innovation in Epidemiological Surveillance, Institut Pasteur Montevideo, Montevideo, Uruguay
Journal: Frontiers in microbiomes, volume 5, article 1777385
Dates: received 29 December 2025; accepted 2 March 2026; published online 24 March 2026
Type: Research article · Language: English
License: CC BY
Identifiers: DOI 10.3389/frmbi.2026.1777385 · PMID 41952964 · PMCID PMC13055624 · OpenAlex W7140159278
Open access: gold, a free copy (OpenAlex)
Status: code verified (how the code is found and verified)
Categories: genetics / omics (modality), human (organism), autism (population), clinical / translational (subfield)
Methods: Statistics, Machine learning, Connectivity
Keywords: 16S rRNA, autism spectrum disorder (ASD), gastrointestinal symptoms (GI), microbiome, oxford nanopore amplicon sequencing
Topic: Gut microbiota and health (Molecular Biology, Biochemistry, Genetics and Molecular Biology), according to OpenAlex
Citations: cited by 1 paper (Europe PMC); 61 references in the paper

Abstract

Autism Spectrum Disorder (ASD) is a complex neurodevelopmental disorder marked by difficulties in communication, social interaction, and restricted, repetitive behaviors. The gut microbiota has emerged as a key factor in the gut-brain axis relevant to ASD. We conducted a cross-sectional study comparing the gut bacterial composition of children with ASD (n=29) and their neurotypical siblings (NT, n=29). To minimize environmental and lifestyle confounders, all pairs were 4 to 10 years old and cohabiting in the same household in Uruguay. We used full-length 16S rRNA gene (V1–V9) sequencing with the latest R10.4.1 Oxford Nanopore Technologies chemistry, enabling high-resolution microbial characterization. While overall β-diversity did not differ significantly between the ASD and NT groups, we identified specific taxonomic shifts. The ASD group was enriched in taxa like Sellimonas, while the NT group showed enrichment of genera like Faecalibacterium and Coprococcus. Furthermore, we found GI symptoms to be significantly more prevalent in the ASD group and some bacterial genera associated with GI symptomatology. In addition, we explored the association of pharmacological treatments. Antipsychotic use was associated with reduced Akkermansia abundance, whereas melatonin and methylphenidate use were associated with the enrichment of Negativibacillus. This study provides novel insights into the gut microbiome of Uruguayan children with ASD, delineating the influence of GI symptoms and pharmacological load on microbial diversity and composition.

Reproduced under the paper's license (CC BY), from the paper cited above.

Code

No file of the authors' code could be read here: it is described below, and read at its source.

fpenalba09

License: none: the authors keep all their rights
State: the link answers, verified on 30 September 2026
Evidence: the link answers
Software Heritage: not checked
Found in: the text, “Bioinformatic analysis”
Not found: README, license file, CITATION.cff, environment file, tests, continuous integration, documentation
Availability: 1 check, the latest on 30 September 2026: the link answers (HTTP 200)
  • 30 September 2026: the link answers (HTTP 200)
At the source: github.com/fpenalba09

Tracing map

Proposed by the machine: these links were found in the paper and verified at the source, without human review. The map will receive a Zenodo DOI once one of the paper's authors has validated it with their ORCID.

What the map holds:

  • 1 repository of the authors' code, each at its verified commit, with its license and how the link was found in the paper;
  • 0 scripts, each with its path and the digest of its content;
  • no match between paragraphs and code yet;
  • neither the text of the paper nor the code itself.

Its JSON (tracing-map.json) is deposited on Zenodo with its DOI once the map is validated.

Data

No dataset and no data link were found in the paper.

Data availability statement

The datasets presented in this study can be found in online repositories. The names of the repository/repositories and accession number(s) can be found in the article/Supplementary Material.

Reproduced under the paper's license (CC BY), from the paper cited above.

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 1, 30 September 2026: the first record

Recorded: type, language, journal, volume, pages, dates, 11 authors, 5 keywords, 1 funder, 55 references.

Cite

This paper

Peñalba, F., Guisande, A., Lamberti, L., Rusiñol, C., Irastorza, M., Konik, F., Iglesias, C., Mendive, P., Garrido, G., Parada, A., & Riera, N. (2026). Gut microbiota and its association with gastrointestinal symptoms and pharmacological treatments in a sibling-matched cohort with autism spectrum disorder. Frontiers in microbiomes, 5, 1777385. https://doi.org/10.3389/frmbi.2026.1777385

BibTeX

@article{penalba2026gut,
author = {Peñalba, Florencia and Guisande, Andreina and Lamberti, Lucía and Rusiñol, Camila and Irastorza, Maite and Konik, Florencia and Iglesias, Claudio and Mendive, Paula and Garrido, Gabriela and Parada, Andrés and Riera, Nadia},
title = {{Gut microbiota and its association with gastrointestinal symptoms and pharmacological treatments in a sibling-matched cohort with autism spectrum disorder}},
journal = {Frontiers in microbiomes},
year = {2026},
month = mar,
volume = {5},
pages = {1777385},
publisher = {Frontiers Media SA},
issn = {2813-4338},
doi = {10.3389/frmbi.2026.1777385},
url = {https://doi.org/10.3389/frmbi.2026.1777385},
pmid = {41952964},
pmcid = {PMC13055624}
}

RIS

TY - JOUR
AU - Peñalba, Florencia
AU - Guisande, Andreina
AU - Lamberti, Lucía
AU - Rusiñol, Camila
AU - Irastorza, Maite
AU - Konik, Florencia
AU - Iglesias, Claudio
AU - Mendive, Paula
AU - Garrido, Gabriela
AU - Parada, Andrés
AU - Riera, Nadia
TI - Gut microbiota and its association with gastrointestinal symptoms and pharmacological treatments in a sibling-matched cohort with autism spectrum disorder
T2 - Frontiers in microbiomes
J2 - Front Microbiomes
PY - 2026
DA - 2026/03/24
VL - 5
SP - 1777385
SN - 2813-4338
PB - Frontiers Media SA
DO - 10.3389/frmbi.2026.1777385
UR - https://doi.org/10.3389/frmbi.2026.1777385
LA - en
ER -

CSL-JSON

{
"id": "10.3389/frmbi.2026.1777385",
"type": "article-journal",
"title": "Gut microbiota and its association with gastrointestinal symptoms and pharmacological treatments in a sibling-matched cohort with autism spectrum disorder",
"container-title": "Frontiers in microbiomes",
"author": [
{
"family": "Peñalba",
"given": "Florencia"
},
{
"family": "Guisande",
"given": "Andreina"
},
{
"family": "Lamberti",
"given": "Lucía"
},
{
"family": "Rusiñol",
"given": "Camila"
},
{
"family": "Irastorza",
"given": "Maite"
},
{
"family": "Konik",
"given": "Florencia"
},
{
"family": "Iglesias",
"given": "Claudio"
},
{
"family": "Mendive",
"given": "Paula"
},
{
"family": "Garrido",
"given": "Gabriela"
},
{
"family": "Parada",
"given": "Andrés"
},
{
"family": "Riera",
"given": "Nadia"
}
],
"container-title-short": "Front Microbiomes",
"volume": "5",
"page": "1777385",
"DOI": "10.3389/frmbi.2026.1777385",
"PMID": "41952964",
"PMCID": "PMC13055624",
"ISSN": "2813-4338",
"publisher": "Frontiers Media SA",
"URL": "https://doi.org/10.3389/frmbi.2026.1777385",
"language": "en",
"issued": {
"date-parts": [
[
2026,
3,
24
]
]
}
}

The tracing map gets a citation of its own once an author has validated it and it has a DOI.

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.3390/nu15071620
Intestinal Barrier Dysfunction and Microbiota-Gut-Brain Axis: Possible Implications in the Pathogenesis and Treatment of Autism Spectrum Disorder.
Journal: Nutrients
In common: autism, clinical / translational, 8 references
[2] doi:10.1186/s12888-026-08178-8 [code]
Machine learning model to identify gut microbiome-derived metabolites as potential biomarkers of autism spectrum disorder: a pilot study.
Journal: BMC psychiatry
In common: autism, clinical / translational, genetics / omics, 5 references
[3] doi:10.1038/s41593-023-01361-0 [code]
Multi-level analysis of the gut-brain axis shows autism spectrum disorder-associated molecular and microbial profiles.
Journal: Nature neuroscience
In common: autism, genetics / omics, 5 references
[4] doi:10.1016/j.gutmic.2026.100006 [code]
From microbes to milestones: Gut bacterial abundances and functional pathways associate with neurodevelopment following preterm birth.
Journal: Gut microbiology
In common: autism, 5 references
[5] doi:10.3389/fmicb.2024.1331130
Microbiota profiling reveals alteration of gut microbial neurotransmitters in a mouse model of autism-associated 16p11.2 microduplication.
Journal: Frontiers in microbiology
In common: autism, genetics / omics, 5 references
[6] doi:10.3390/biomedicines11102633
Machine Learning Algorithms Applied to Predict Autism Spectrum Disorder Based on Gut Microbiome Composition.
Journal: Biomedicines
In common: autism, 4 references
[7] doi:10.3389/fmicb.2022.1009502
Effect of stigma maydis polysaccharide on the gut microbiota and transcriptome of VPA induced autism model rats.
Journal: Frontiers in microbiology
In common: autism, genetics / omics, 4 references
[8] doi:10.3389/fmicb.2026.1885281
Washed microbiota transplantation improves clinical symptoms, gut microbiota, and metabolic profiles in autism spectrum disorder in a twin cohort.
Journal: Frontiers in microbiology
In common: autism, clinical / translational, genetics / omics, 3 references
[9] doi:10.1016/j.xcrm.2026.102655 [code]
An integrative multi-omics approach identifies microbiome alterations linked to pathological and behavioral features in autism spectrum disorder.
Journal: Cell reports. Medicine
In common: autism, genetics / omics, 3 references
[10] doi:10.1038/s41467-025-58459-1 [code]
Relationships between brain activity, tryptophan-related gut metabolites, and autism symptomatology.
Journal: Nature communications
In common: autism, genetics / omics, 3 references

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.

Add the badge to the code's README

OSCR: the badge of this paper

If you are an author or a maintainer of this paper's code, you can add this badge. It says what OSCR knows of the paper (its code, its validated tracing map) and links the code to this page. Paste one of these snippets under the README's title. Keep the two marks around it, so that the badge can be replaced in place and is never added twice. OSCR changes nothing in your repository.

Markdown
<!-- oscr-badge:start -->
[![OSCR](https://openscicode.org/badge/doi/10.3389/frmbi.2026.1777385.svg)](https://openscicode.org/badge/doi/10.3389/frmbi.2026.1777385)
<!-- oscr-badge:end -->
reStructuredText
.. oscr-badge:start

.. image:: https://openscicode.org/badge/doi/10.3389/frmbi.2026.1777385.svg
   :target: https://openscicode.org/badge/doi/10.3389/frmbi.2026.1777385
   :alt: OSCR

.. oscr-badge:end
HTML
<!-- oscr-badge:start -->
<a href="https://openscicode.org/badge/doi/10.3389/frmbi.2026.1777385"><img src="https://openscicode.org/badge/doi/10.3389/frmbi.2026.1777385.svg" alt="OSCR"></a>
<!-- oscr-badge:end -->

If you choose to, you can have the badge kept up to date for you, with oscr badge --write from the command line or with the GitHub Action in your repository's workflows. Every other form and option (a card, AsciiDoc, LaTeX, shields.io) is on the badge page.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion, reproductions, activity

Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.

Report a mismatch between the code and the paper · Report a code error (signed in)

Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.

Report a reproduction failure (signed in)

Versions of its code: the releases of its code tied to a version of this paper (the preprint, the accepted manuscript, the version of record…), each with the tracing map versioned with it.

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.